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1  | INTRODUC TION
TGFBI-linked corneal dystrophy is an autosomal dominant dis-
order, caused by mutations in the transforming growth factor 
β-induced (TGFBI) gene on chromosome 5q31, while granular 
corneal dystrophy type 2 (GCD2) is only caused by an arginine 
to histidine substitution at codon 124 of the TGFBI gene.1 GCD2 
is pathologically characterized by the age-dependent progressive 
accumulation of mutant-TGFBI proteins (TGFBIp), in the corneal 
epithelium and stroma, followed by interference in the transpar-
ency of the cornea.1 Although the worldwide frequency of these 
disorders is not known, an epidemiological study of the popu-
lation of South Korea reported an estimated frequency of 11 in 
10 000 for GCD2.2
The avascular tissue of the cornea is transparent at the frontal 
surface of the eye and consists of three major layers: the outer 
 
Received: 11 November 2019  |  Revised: 17 February 2020  |  Accepted: 17 April 2020
DOI: 10.1111/jcmm.15646  
O R I G I N A L  A R T I C L E
Lysosomal dysfunction of corneal fibroblasts underlies the 
pathogenesis of Granular Corneal Dystrophy Type 2 and can be 
rescued by TFEB
Seung-il Choi1  |   Jong Hwan Woo1 |   Eung Kweon Kim1,2,3
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, 
provided the original work is properly cited.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
1Corneal Dystrophy Research Institute, 
Yonsei University College of Medicine, 
Seoul, South Korea
2Department of Ophthalmology, Yonsei 
University College of Medicine, Seoul, South 
Korea
3Institute of Vision Research, Yonsei 
University College of Medicine, Seoul, South 
Korea
Correspondence
Eung Kweon Kim, Department of 
Ophthalmology, Yonsei University College of 
Medicine, 134 Shinchon-dong, Seodaemun-
ku, Seoul 120-752, Korea.
Email: eungkkim@yuhs.ac
Funding information
Ministry of Education, Grant/Award 
Number: NRF-2016R1D1A1B03934794; 
Ministry of Health & Welfare, Republic of 
Korea, Grant/Award Number: HI16C1009
Abstract
Granular corneal dystrophy type 2 (GCD2) is the most common form of transforming 
growth factor β-induced (TGFBI) gene-linked corneal dystrophy and is pathologically 
characterized by the corneal deposition of mutant-TGFBIp. The defective autophagic 
degradation of pathogenic mutant-TGFBIp has been shown in GCD2; however, its 
exact mechanisms are unknown. To address this, we investigated lysosomal func-
tions using corneal fibroblasts. Levels of cathepsins K and L (CTSK and CTSL) were 
significantly decreased in GCD2 cells, but of cathepsins B and D (CTSB and CTSD) 
did not change. The maturation of the pro-enzymes to their active forms (CTSB, 
CTSK and CTSL) was inhibited in GCD2 cells. CTSL enzymes directly degraded both 
LC3 (autophagosomes marker) and mutant-TGFBIp. Exogenous CTSL expression dra-
matically reduced mutant-TGFBIp in GCD2 cells, but not TGFBIp in WT cells. An in-
creased lysosomal pH and clustered lysosomal perinuclear position were found in 
GCD2 cells. Transcription factor EB (TFEB) levels were significantly reduced in GCD2 
cells, compared to WT. Notably, exogenous TFEB expression improved mutant-TGF-
BIp clearance and lysosomal abnormalities in GCD2 cells. Taken together, lysosomal 
dysfunction in the corneal fibroblasts underlies the pathogenesis of GCD2, and TFEB 
has a therapeutic potential in the treatment of GCD2.
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epithelium, a thick stroma with keratocytes also known as corneal 
fibroblasts and the inner endothelium.3 Keratocytes are normally 
quiescent and generally only become activated after corneal in-
jury.3 The role of keratocytes in the corneal stroma is to maintain 
corneal transparency and structures through the degradation and 
synthesis of cornea-specific extracellular matrix (ECM) compo-
nents4;damage to these cells may result in impaired vision.
Autophagy is a major intracellular degradation and recycling 
system that is ubiquitous in eukaryotes. This catabolic process is 
a response to cellular stress and pathophysiological conditions, 
whereby cellular organelles and components are engulfed into 
double-membrane vesicles called autophagosomes and eventually 
delivered to lysosomes for degradation.4,5 The final step of autoph-
agy is the degradation of the cargo molecules within the lysosomes.
Lysosomes are membrane-enclosed cellular organelles that con-
sist of two types of lysosomal proteins: lysosomal acid hydrolases 
and lysosomal membrane proteins. The lysosomal acid hydrolases 
are involved in the degradation of lysosome cargo and there are 
more than 60 different types that degrade proteins, nucleic acids, 
carbohydrates and lipids.6 Among them, the cathepsins (CTSs) are a 
major class of lysosomal protease, which are especially important for 
autophagy.7–9 CTSs family consists of aspartic, cysteine and serine 
CTSs, and they are synthesized as immature (inactive) pro-CTSs that 
are proteolytically processed to form mature (active) CTSs.10,11 Most 
lysosomal CTSs are functionally processed to their mature forms (or 
active form) at acidic pH, as CTSs are stable and active at a low pH.
TGFBIp, which is ubiquitously expressed,12 enters through the 
autophagy pathway13 and caveolae-mediated endocytosis14 into lyso-
somes, where the proteins are degraded. In GCD2 corneal fibroblasts, 
mutant-TGFBIp accumulates in the lysosomal compartments due to 
defective autophagy.13,15–17 Furthermore, this accumulation of mu-
tant-TGFBIp leads to cell death of corneal fibroblasts.13 Several stud-
ies have found that the reduction and clearance of mutant-TGFBIp in 
the corneal fibroblasts is a viable therapeutic strategy for the treat-
ment of TGFBI-linked dystrophic patients.16–19 However, there are no 
therapies or drugs currently available for the treatment of GCD2.
We hypothesized that the accumulation of the pathogenic mu-
tant-TGFBIp in the corneal fibroblasts may be caused by lysosomal 
abnormalities and that the enhancement of lysosomal function 
might counteract the progression of TGFBI-linked corneal dystro-
phies. In this study, we tested the lysosomal function of the corneal 
fibroblasts and the therapeutic effects of exogenous TFEB expres-
sion and evaluated the efficacy of this treatment strategy on GCD2 
corneal fibroblasts.
2  | MATERIAL S AND METHODS
2.1 | Antibodies, inhibitors and treatments
All antibodies, reagents and inhibitors that were used in this in-
vestigation are listed in Tables S1 and S2. All inhibitors and drugs 
were dissolved in dimethyl sulfoxide. After 16-24 hours subcultures, 
corneal fibroblasts were treated with each inhibitor and the relevant 
drugs in the fresh growth medium.
2.2 | Culture of corneal fibroblasts
Primary cultured corneal fibroblasts were prepared from heterozy-
gous (HT) or homozygous (HO) GCD2 patients and normal (wild-type, 
WT) healthy corneas from the eye bank, which were obtained during 
penetrating or lamellar keratoplasty. Donor confidentiality was main-
tained according to the Declaration of Helsinki and was approved by 
Severance Hospital IRB Committee (CR04124), Yonsei University. 
GCD2 was diagnosed by DNA sequencing analysis of BIGH3 gene 
mutations. This study used WT (n = 4), HT (n = 1), and HO (n = 3) 
human corneal fibroblasts, which were immortalized by expression of 
the catalytic subunit of human telomerase (hTERT).14 Corneal fibro-
blasts were cultured in Dulbecco's modified Eagle's medium (Corning, 
Manassas, VA, USA) supplemented with 10% FBS (Corning), 100 IU/
mL penicillin (Corning), and 100 mg/mL streptomycin (Corning) at 
37°C in a humidified incubator with 95% air and 5% CO2.
2.3 | CTSL and TFEB retrovirus plasmid 
construction and transduction
Each human full-length TFEB ORF cDNA clone was obtained from 
OriGene Technologies (SC122773: OriGen Rockville, MD, USA) and the 
human full-length CTSL ORF cDNA cloned from the total RNA of the cor-
neal fibroblasts were cloned into the pcDNA3.1 TOPO vector (Invitrogen, 
Carlsbad, CA, USA) using standard RT-PCR technology. Supporting infor-
mation provides more additional detail methods (Methods S1).
2.4 | Preparation of cell lysates, Western blots and 
immunoprecipitation analysis
Cell lysates from corneal fibroblasts were prepared in a radio-im-
munoprecipitation assay buffer (150 mmol/L NaCl, 1% NP-40, 0.5% 
deoxycholate, 0.1% SDS, 50 mmol/L Tris-HCl, pH 7.4) containing a 
protease inhibitor (Complete Mini Protease Inhibitor Tablet, Roche 
#1836170). Supporting information provides more additional detail 
methods (Methods S2).
For immunoprecipitation, cell lysates were each divided into two 
equal concentrations and immunoprecipitated with anti-TFEB or anti-
14-3-3 and Dynabeads coated with sheep anti-mouse IgG (Invitrogen). 
The immunoprecipitated proteins were analysed by Western blots.
2.5 | Immunofluorescence staining and 
confocal microscopy
Corneal fibroblasts were grown on culture slides (BD Falcon Labware, 
REF 354108) that were permeabilized and fixed in methanol at −20°C 
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for 3 minutes. Supporting Material provides more detail methods 
(Methods S3).
2.6 | Acridine orange staining
It has been established that acridine orange accumulates in 
acidic organelles.20 Cells were cultured on a cover glass slide 
chamber, followed by the designated treatments. Briefly, cor-
neal fibroblasts were exposed to 0.5 μg/mL acridine orange 
(Sigma-Aldrich) for 15 minutes at 37°C.21 After washing with 
PBS three times to remove excess acridine orange, the lysosomal 
structures were visualized with a Zeiss LSM700 confocal micro-
scope (Carl Zeiss).
2.7 | Determination of the lysosomal pH with a 
pH indicator
Changes in lysosomal pH were evaluated using the LysoSensor 
Yellow/Blue DND-160 reagents following the manufacturer's 
instructions. Cells (1 × 106-7/mL) were exposed to Lysosensor 
yellow/blue DND-160 (Invitrogen) at a final concentration 
of 10 μmol/L for 1 hour in PBS. Cells were then washed three 
times with ice-cold PBS and kept on ice until just before starting 
observation.
2.8 | RNA isolation and quantitative real-time PCR
Total RNA was isolated as described by the manufacturer using 
Trizol reagent (Invitrogen). Quantitative real-time PCR (RT-qPCR) 
was performed using Taq-Man® Universal PCR Master Mix II 
(Applied Biosystems) with specific primers (Table S3). The mRNA 
levels β-actin and GAPDH were used to normalize the expression 
of target genes. Relative quantification was performed using system 
software based on the 2−DDCt method.
2.9 | Subcellular fractions
Nuclear fractions and the cytoplasm were prepared using a NE-
PER® nuclear and cytoplasmic extraction reagents (Pierce, 78833) 
according to the manufacturer's protocol. Supporting information 
provides more detail methods (Methods S4).
2.10 | In vitro cleavage assays of TGFBIp and LC3
Human CTSL (C6854: Sigma-Aldrich) was used to digest TGFBIp and 
LC3 proteins in vitro. Supporting information provides more detail 
methods of in vitro cleavage assay (Methods S5).
2.11 | Imaging
For analysis of the TFEB in the nucleus, Z-stack images were cap-
tured at ×20 and ×60 magnifications using the Zeiss LSM 700 con-
focal microscope (Carl Zeiss) and analysed using the Zeiss LSM ZEN 
2012 software (Carl Zeiss).
2.12 | Statistics
Statistical significance was assessed by two-tailed Student's t test 
or one-way ANOVA (for multiple comparisons) using the scientific 
graphing analysis software (Prism, version 5.0; GraphPad Software 
Inc, San Diego, CA, USA). P values < 0.05 were considered statisti-
cally significant.
3  | RESULTS
3.1 | Altered processing and levels of CTSs in GCD2 
corneal fibroblasts
Our previous study showed that the pathogenic mutant-TGFBIp accu-
mulates in the lysosomal compartments of GCD2 corneal fibroblasts.13 
This study indicates that lysosomes may be functionally abnormal in 
GCD2 corneal fibroblasts. Accordingly, we first analysed the levels 
of CTSs. The results showed that the levels of CTSK and CTSL were 
significantly reduced in GCD2 corneal fibroblasts compared to WT, 
but the levels of CTSB and CTSD did not differ between the two cells 
(Figure 1A,B). We also measured the levels of CTSs that were in their 
active form. Western blot analysis showed that the active or matured 
forms (M) of CTSB, CTSK and CTSL were significantly decreased in 
GCD2 corneal fibroblasts, compared with WT (Figure 1A,C). In con-
trast, the levels of CTSD did not change (Figure 1A,B). We also ana-
lysed the ratio of the immature (IM) CTS to the active form (Figure 1A). 
The ratios of immature CTSB and CTSL to their active forms were sig-
nificantly increased in GCD2 corneal fibroblasts compared with WT 
(Figure 1A,D). However, the ratio of the immature forms of CTSD and 
CTSK to their active forms did not differ between GCD2 and WT cor-
neal fibroblasts (Figure 1A,D). Additionally, an increased level of CTSD 
intermediate proenzyme (ITM; 48 kDa) was observed in GCD2 HO 
corneal fibroblasts (Figure 1A).
Confocal microscopy showed much weaker intracellular fluores-
cence intensity for CTSK and CTSL in GCD2 HO corneal fibroblasts, 
but not for CTSD (Figure 1E,F). In addition, the mRNA expression 
analysis from RT-qPCR showed that the mRNA levels of CTSK and 
CTSL were significantly reduced, but those of CTSB and CTSD were 
not significantly different in GCD2 corneal fibroblasts compared with 
WT (Figure 1G). Because we developed only one line of HT corneal 
fibroblasts, we limited our comparison between normal and patho-
logical states to WT and HO cells, respectively. Accordingly, all data 
presented subsequent to Figure 1 are restricted to these cell lines.
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3.2 | Perturbation of lysosomal acidification in 
GCD2 corneal fibroblasts
Pro-CTSs or immature CTSs are proteolytically processed to active 
or mature CTS forms upon acidification in lysosomes and endolys-
osomes.22,23 Accordingly, high levels of immature CTSs in GCD2 
corneal fibroblasts (Figure 1A,D) indicate altered lysosomal acidifi-
cation. To confirm this, the lysosomal acidification was assessed by 
vital staining with acridine orange. This dye is an acidotropic weak 
base, which is taken up by living cells and accumulates in acidified 
compartments such as the lysosomes.24,25 Acridine orange has a 
green fluorescence at low concentrations and red at high concen-
trations. Consequently, when corneal fibroblasts were stained with 
acridine orange, the nuclei and the cytoplasm showed green fluores-
cence, whereas the acidified lysosomes showed red fluorescence in 
a granular pattern in the cytoplasm. WT corneal fibroblasts showed 
intact lysosomal compartments, as indicated by the cytoplasmic red 
fluorescence (Figure 2A). In contrast, most GCD2 corneal fibroblasts 
showed markedly decreased red fluorescence (Figure 2A), indicating 
an elevated lysosomal pH. To further confirm whether the decreased 
red fluorescence resulted from a loss of lysosomal acidification in 
GCD2 corneal fibroblasts, we employed bafilomycin A1, a potent 
F I G U R E  1   Altered levels and maturation of cathepsins (CTSs) in GCD2 corneal fibroblasts. A, Western blotting analysis of CTSB, CTSD, 
CTSK, CTSL and GAPDH in WT and GCD2 corneal fibroblasts. WT, wild-type corneal fibroblasts; HO, homozygous corneal fibroblasts; 
HT, heterozygous corneal fibroblasts; GCD2, granular corneal dystrophy type 2; LE, long-short exposure; SE, short exposure; IM, immature 
form (or inactive form); ITM, intermediate form (intermediate proenzyme); M, mature form (or active form); kD, kilodalton. B, Quantification 
of relative band intensities including IM, ITM, and M forms (total levels) of CTSs in (A). Data were normalized against GAPDH (n ≥ 3). C, 
Quantification of relative band intensities of matured forms (M) of CTSs in (A). Data were normalized against GAPDH (n ≥ 3). D, Quantitative 
ratio of relative band intensities of immature (IM) of CTSs in (A). Data were normalized against GAPDH (n ≥ 3). E, Representative 
immunofluorescence images of STSD, CTSK, and CTSL in WT and HO corneal fibroblasts. F, Quantification of staining intensities of CTSD, 
STSK and CTSL in (E). At least 30 corneal fibroblasts were analysed for each group from three independent experiments. G, Transcripts 
levels of CTSB, CTSD, CTSK and CTSL. The mRNA expression of CTSs in WT and GCD2 corneal fibroblasts was analysed by real-time RT-
PCR. Data were normalized against β-actin (n = 3). Statistical significance was determined by Student's t test. Data represent the mean ± SD. 
*P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001. NS, not significant
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inhibitor of vacuolar-type H+-ATPase (V-ATPase) that indirectly in-
hibits fusion between the autophagosome and lysosomes by increas-
ing the lysosome pH. As expected, the treatment of both corneal 
fibroblasts with bafilomycin A1 for 1 hour before acridine orange 
staining caused complete disappearance of the red fluorescence, 
whereas the green fluorescence remained (Figure 2A). In addition, to 
examine specifically the luminal pH of the lysosomes, we performed 
live imaging assays using a pH-sensitive fluorescent dye, LysoSensor 
Yellow/Blue DND-160. This dye is characterized by its spectral prop-
erties which produce yellow fluorescence in an acidic environment 
and blue in an alkaline environment. Confocal imaging of WT and 
GCD2 corneal fibroblasts treated with the DND-160 confirmed that 
most of WT corneal fibroblasts displayed a yellow fluorescence (pH 
of 4-5), and GCD2 corneal fibroblasts displayed a blue fluorescence 
(pH 6-7) (Figure 2B,C). To further explore the mechanisms underlying 
the lysosomal acidification in GCD2 corneal fibroblasts, we assayed 
the level of V-ATPase, as the lysosomal pH is regulated by compo-
nents of the V-ATPase complex that participates in lysosomal acidifi-
cation.26,27 Interestingly, the Western blots showed that the relative 
level of the E subunit of the V-ATPase was significantly reduced in 
GCD2 corneal fibroblasts compared with WT (Figure 2D,E).
3.3 | Lysosomes are highly concentrated in the 
perinuclear regions of the GCD2 corneal fibroblasts
The shape and distribution of lysosomes correlated with the changes in 
the intracellular pH.28,29 Therefore, we investigated the distribution of 
lysosomes. The confocal images showed that the lysosome-associated 
membrane protein 2 (LAMP2), a specific lysosomal marker, was distrib-
uted in the peripheral area of the WT corneal fibroblasts (Figure 3A). 
Lysosomal distribution pattern in GCD2 HO corneal fibroblasts was 
highly concentrated in the perinuclear regions (Figure 3A). Furthermore, 
quantification of the intensities of LAMP2 staining was significantly 
elevated in the HO corneal fibroblasts compared to WT (Figure 3B). 
Western blot analysis also showed that LAMP2 protein levels were sig-
nificantly increased (Figure 3C,D), whereas mRNA levels in GCD2 cor-
neal fibroblasts did not differ compared with in WT (Figure 3E).
F I G U R E  2   Analysis of lysosomal acidification in GCD2 corneal fibroblasts. A, Acridine orange (AO) uptake in corneal fibroblasts. 
Representative images of AO-stained fibroblasts that were untreated or treated with 200 nmol/L Baf A1 (Bafilomycin A1) for 4 h. Red 
staining is associated with acidic vesicles, whereas green staining is associated with high pH. Nucleic acids are stained green. Scale bar 
20 µm. B, Altered lysosomal pH in WT and GCD2 HO corneal fibroblasts. The corneal fibroblasts were loaded with 5 µmol/L LysoSensor 
Yellow/Blue DND-160 for 5 min and immediately imaged under a confocal microscope. Dual-emission ratio-metric measurement of 
lysosomal pH using LysoSensor Yellow/Blue DND-160. These pseudo-coloured images were constructed from two emission images. In 
these images, the fluorescence near pH 4 was pseudo-coloured yellow-green and fluorescence near pH 7 was pseudo-coloured blue. C, 
Quantification of staining intensities of the LysoSensor Yellow/Blue DND-160. At least 60 corneal fibroblasts were analysed for each group. 
D, Western blot analysis of ATPase E levels in WT and GCD2 HO corneal fibroblasts. The total protein extracted from WT and GCD2 HO 
corneal fibroblasts was analysed by using anti-V-ATPase and GAPDH antibodies. GAPDH was used as a loading control. E, Quantification 
of relative band intensities of V-ATPase in (D). The bands were normalized against GAPDH (n = 3). Data are representative of three 
independent experiments. Values indicate the means ± SD. Statistical significance was determined by Student's t test. *P ≤ 0.05; **P ≤ 0.01. 
NS, not significant
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3.4 | CTSL is the degrading 
enzyme of TGFBIp and exogenous CTSL expression 
promotes the clearance of mutant-TGFBIp
The delayed degradation of the mutant-TGFBIp within the lysosomes 
and the autophagolysosome (Data S1)13,14 and the reduced expres-
sion of CTSL and CTSK (Figure 1) indicate that CTSL and CTSK could 
degrade the mutant-TGFBIp in lysosomes. Accordingly, to investigate 
whether CTSK and CTSL had the ability to degrade the TGFBIp, we 
treated several CTS inhibitors with WT and HO corneal fibroblasts, 
and then assayed the levels of TGFBIp. The results showed that CTSB 
inhibitor significantly reduced the levels of TGFBIp in both WT and HO 
corneal fibroblasts (Figure 4A,B). Conversely, CTSL inhibitor resulted 
in the significant accumulation of TGFBIp in both WT and GCD2 cor-
neal fibroblasts (Figure 4A,B). Additionally, the TGFBIp is accumulated 
in the presence of CTSL inhibitor, in a dose- (50-150 µmol/L: Figure 4C) 
and time- (1-7 hours: Figure 4D) dependent manner, in both WT and 
GCD2 corneal fibroblasts. These results indicate that CTSL may de-
grade both WT- and mutant-TGFBIp within the lysosomes. Therefore, 
we investigated whether CTSL could degrade the TGFBIp directly 
through in vitro cleavage assay. As expected, the treatment with 
CTSL enzyme resulted in the disappearance of the bands for both the 
TGFBIp and mutant-TGFBIp (Figure 4E, lane 2 and 5). Additionally, the 
smaller unit (0.25) of CTSL did not degrade TGFBIp or the mutant-TGF-
BIp (Figure 4F, lane 2 and 6), whereas the medium and large units (1.25 
and 2.5) degraded both (Figure 4F, lane 3 and 4, and 7 and 8). Similarly, 
the degradation of TGFBIp by CTSL at pH 5.5-9 was determined by 
Western blotting. It was found that in the acidic lysosome (pH 5.5), 
CTSL was able to degrade the TGFBIp (Figure 4G, lane 2 and 6) and 
that there was partial cleavage of the TGFBIp at pH 7-9 (Figure 4G, 
lane 3 and 4 in TGFBIp, and lane 7 and 8 in mutant-TGFBIp). Further, we 
determined that the optimum pH for CTSL to degrade TGFBIp was 4.5 
(Data S2). In addition, we are showed that CTSL is a major degrading 
F I G U R E  3   Altered lysosomal distributions in GCD2 corneal fibroblasts. A, Representative images of LAMP2 (lysosomal marker) staining 
in WT and GCD2 corneal fibroblasts. The corneal fibroblasts were methanol-fixed and immunostained with anti-LAMP2 (green: lysosomal 
marker) and counterstained with DAPI (blue: nuclear marker). B, Quantification of staining intensities of LAMP2 in (A). At least 40 corneal 
fibroblasts were analysed for each group (n ≥ 3). C, Western blots analysis of LAMP2 levels in WT and GCD2 corneal fibroblasts. D, 
Quantification of relative band intensities of LAMP2 levels in (C). Data were normalized against β-actin (n = 3). E, Real-time RT-PCR analysis 
of LAMP2 mRNA levels in WT and GCD2 corneal fibroblasts. Quantification of relative levels of LAMP2 mRNA. Data were normalized 
against β-actin (n = 3). Data are representative of three independent experiments for A and C and two independent experiments for E. 
Differences between the values were analysed by Student's t test. *P ≤ 0.05; **P ≤ 0.01. NS, not significant
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enzyme of LC3-II in autophagolysosome and lysosomes through inhibi-
tor (Data S3A-F) and in vitro assay with CTSL enzyme (Data S3G-I).
3.5 | Exogenous CTSL expression promotes the 
clearance of pathogenic mutant-TGFBIp
The ability of CTSL to clear mutant-TGFBIp was then investigated. In 
this test, to overcome the very low or lack of transfection efficiency 
of the corneal fibroblasts, we used a lentivirus-based gene deliv-
ery system. First, the lent-CTSL infection led to the enhancement of 
the CTSL in both the WT and HO corneal fibroblasts (Figure 5A,B, 
lanes 2, 4, 6, 8 and 10). Second, we assayed the effects of the CTSL 
overexpression on the levels of the TGFBIp. Interestingly, the re-
sults showed that the mutant-TGFBIp was significantly reduced in 
the HO-Lenti-CTSL cells (Figure 5A, lanes 6, 8 and 10), but not in 
the WT-Lenti-CTSL corneal fibroblasts (Figure 5A, lanes 2 and 4). 
Furthermore, enhanced levels of the CTSL led to an increased ratio 
of LC3-II/LC3-I in the WT corneal fibroblasts (Figure 5A, lanes 2 and 
4, and Figure 5B, lanes 6), but reduced ratio of LC3-II/LC3-I in the 
GCD2-Lenti-CTSL corneal fibroblasts (Figure 5A,B: lanes 6 and 8, 
and 10). We also investigated whether the reduced mutant-TGFBIp 
levels resulted from the induction of autophagy or the activation 
of CTSL. We used bafilomycin A1 in the WT and GCD2 corneal fi-
broblasts infected with or without Lenti-CTSL overexpression. 
Bafilomycin A1 significantly enhanced the levels of CTSL, TGFBIp, 
and LC3-II in the Lenti-CTSL infected and none-infected WT cells, 
and the GCD2 cells (Figure 5C,D,E,F: lane 2, 3, 5 and 6, and 8, 9, 
11 and 12, respectively). Furthermore, bafilomycin A1 significantly 
enhanced the levels of CTSL, TGFBIp and LC3-II in the Lenti-CTSL-
infected GCD2 cells, compared with the GCD2 cells, but not the 
Lenti-CTSL-infected WT and WT cells (Figure 5C,D,E,F: lane 1, 2 
and 3 compared to 4, 5 and 6, respectively). These data indicate 
that enhancing CTSL could remove the mutant-TGFBIp through the 
activation of autophagy in the GCD2 cells.
Previously, it has been described that apoptosis was induced 
in the cells expressing antisense CTSL RNA30 and in the CTSL gene 
knock-out mice.31 Accordingly, we have examined the effects of 
CTSs inhibition between the GCD2 and WT cells. These results 
showed that the cell viability of the GCD2 cells was the most sus-
ceptible to CTSL inhibition. Collectively, these results suggest that 
reduced CTSL with GCD2 may provide the additional cytotoxicity to 
pathogenic mutant-TGFBIp (Data S4).
3.6 | TFEB was reduced in GCD2, and 
exogenous TFEB expression rescues the lysosomal 
abnormalities and GCD2 corneal fibroblasts from 
CTSL inhibitor-induced apoptosis
Recently, the TFEB has been identified as a master regulator of lyso-
somal biogenesis.26,32 TFEB regulates the expression of various au-
tophagy- and lysosome-related proteins, including CTSs and ATG.26,32 
Accordingly, we assayed the levels and activity of TFEB. The result 
showed that the level of TFBE (Figure 6A,B), the interaction between 
14-3-3 and TFEB (Figure 6C-F), and the nuclear localization of TFEB 
(Figure 6G-I) was significantly reduced in GCD2 corneal fibroblasts 
compared with WT cells.
F I G U R E  4   Identification of CTSs in the lysosomal degradation of TGFBIp. A, TGFBIp levels in WT and HO corneal fibroblasts, which 
were treated with inhibitors of CTSB, CTSD, CTSK and CTSL were analysed by Western blotting with an anti-TGFBIp antibody. CTS i: 
CTS inhibitor. B, Quantification of relative band intensities of TGFBIp in (A). Data were normalized against GAPDH (n = 3). (C,D) Western 
blot analyses were performed to evaluate the dose- and time-dependent effects of CTSL i on TGFBIp levels in WT and GCD2 HO corneal 
fibroblasts. E, CTSL cleaved TGFBIp and mutant-TGFBIp. TGFBIp was digested with 2.5 m units of CTSL for 2 h at 37°C in pH 5.5, with or 
without CTSL i in vitro. An uncleaved TGFBIp control sample was incubated in buffer without enzyme for 2 h at 37°C at pH 5.5. Samples 
were analysed by Western blotting with an anti-TGFBIp antibody. −: untreated; +: treated; CTSL i: CTSL inhibitor. (F,G). Western blot analysis 
showing the effects of different CTSL i doses (F) and pH (G) on the degradation of TGFBIp. TGFBIp and mutant-TGFBIp were incubated 
with different concentrations of CTSL and pH for 2 h at 37°C in vitro and analysed by Western blotting. Data are representative of three 
independent experiments for (A) and two independent experiments for (C–G). Differences between the values were analysed by one-way 
ANOVA. *P ≤ 0.05; **P ≤ 0.01. NS, not significant
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TFEB plays an essential role in cellular homeostasis and has 
provided us with a novel tool to modulate lysosomal biogene-
sis and function, and autophagy.24,25 Accordingly, we examined 
whether enhancing TFEB could recover the altered CTSs levels 
and lysosomal dysfunction and if it could also clear mutant-TG-
FBIp. Importantly, the exogenous TFEB expression significantly 
promoted the reduction of mutant-TGFBIp levels (Figure 7A,B). 
Western blots also showed that exogenous TFEB expression sig-
nificantly increased the protein levels of LC3-II, CTSB, CTSD, 
CTSK, CTSL and V-ATPase E, but not CTSB and CTSD (Figure 7A,B). 
Further, the immunofluorescence confocal images showed greatly 
enhanced levels of TFEB in the cytosol and nucleus of GCD2 HO-
Lenti-TFEB corneal fibroblasts compared with in GCD2 HO cells 
(Figure 7C). Furthermore, TFEB expression significantly inhibited 
the cleavage of PARP1 and procaspase-3 induced by CTSL inhibitor 
(Figure 7D,E).
4  | DISCUSSION
We here evaluated the lysosomal roles in the intracellular accumu-
lation of mutant-TGFBIp and concluded that the accumulation of 
this pathogenic mutant-TGFBIp by defective autophagy is caused 
by lysosomal dysfunction and that TFEB activation could be ex-
tremely important as a potential therapeutic target in treatments 
for GCD2.
To study the pathogenesis of GCD2, we established WT, HT 
and HO lines from primary corneal fibroblasts. Although we found 
differences between HT and WT primary corneal fibroblasts in 
previous study,5,33 we were unable to determine statistical signif-
icance in this study, as only one line of HT cells was established. 
Consequently, we only used data from WT and HO cells in this 
study to examine the differences between normal and patholog-
ical states.
Our findings demonstrate that altered maturation and reduced 
levels of CTSs in GCD2 corneal fibroblasts. Considering that CTSL is 
a TGFBIp-degrading enzyme, the accumulation of mutant-TGFBIp in 
lysosomes and autophagolysosomes13 could be caused by reduced 
CTSL levels in GCD2 corneal fibroblasts. This is also supported by the 
finding that the exogenous CTSL expression levels reduced the mu-
tant-TGFBIp in GCD2 corneal fibroblasts. Although the exact mecha-
nisms of reduced CTSK and CTSL still need to be elucidated, we here 
suggest that reduced TFEB in GCD2 corneal fibroblasts may lead to 
altered levels of CTSs, because TFEB regulates the expression of most 
lysosomal enzymes, including CTSs.26,27,32 Moreover, the exogenous 
TFEB expression reversed the levels of CTSL, including several CTSs.
Since the lysosomal alkalization is associated with chronic 
changes in autophagy and lysosomal degradation pathways, the 
elevated lysosomal pH could cause the impaired autophagic clear-
ance of mutant-TGFBIp and result in their accumulation in the 
lysosomes of GCD2 corneal fibroblasts. This interpretation is sup-
ported by two studies showing that elevated lysosomal pH caused 
F I G U R E  5   Death of GCD2 corneal fibroblasts are induced by inhibition of CTSB and CTSL. A, Cell viability analysis in WT and GCD2 
corneal fibroblasts treated with inhibitors of CTSL and CTSB. WT, HT and HO corneal fibroblasts were exposed to CTSs i for 16 h, and 
quantitative cell viabilities were estimated using PrestoBlue cell viability reagent (n ≥ 3). B, Apoptosis analysis in WT and GCD2 HO 
corneal fibroblasts treated with inhibitors of CTSL and CTSB for 16 h. PARP1 and β-actin were determined by Western blotting. Cleaved 
PARP1 showed two major fragments migrating at 113 and 89 kD. C, Quantification of relative band intensities of Cl-PARP1 in B (n = 3). 
D, Representative phase-contrast photomicrographs of CTSL i-treated WT and HO corneal fibroblasts (n ≥ 3). X200. Cl-PARP1, Cleaved 
PARP1. CNT, corneal. NS, not significant. Results are representative of three independent experiments. Values are expressed as the 
mean ± SD. Statistical tests were as follows: one-way ANOVA for (A) and Student's t test for (C). *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001. NS, not 
significant
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the defective autophagic clearance of pathogenic molecules.34,35 
Collectively, these data indicate that elevated lysosomal pH may 
be a key factor in the accumulation of mutant-TGFBIp in GCD2 
corneal fibroblasts.
Lysosomal pH controls the maturation of lysosomal hydrolases 
and the processing of certain hydrolases,36 including CTSs.37 Even 
a minimal rise in pH is sufficient to depress lysosomal enzymatic 
activity and to slow down the degradation of cellular materials.38 
These studies indicate that increased immature forms of CTSB and 
CTSL in GCD2 corneal fibroblasts result from elevated lysosomal 
pH. Moreover, while the immature forms of CTSB and CTSL were 
elevated in GCD2 corneal fibroblasts, the maturation of CTSD and 
CTSK was not different between WT and GCD2 corneal fibroblasts. 
These results reveal that the optimum pH of individual CTSs in acti-
vation and maturation may vary. This interpretation is also supported 
by previous studies that showed that the maturation of several CTSs 
could be affected by other CTSs39 and by self-maturation.30
The intracellular distribution of the lysosomes found at the peri-
nuclear area near the microtubule-organizing centre (MTOC) and at 
the periphery of the cells.31 Lysosomes are functionally influenced by 
their positioning in cells.40 For example, perinuclear lysosomes can 
facilitate the fusions between lysosomes and autophagosomes, be-
cause these fusions primarily occur in the perinuclear area. Further, 
lysosomal pH is heterogeneous and affects lysosomal distribution.29 
Hence, peripheral lysosomes are more alkaline than perinuclear ly-
sosomes.41 Our previous study indicated that the fusions between 
lysosomes and autophagosomes were delayed in GCD2 corneal fi-
broblasts,13 and the data from this study show that the lysosomal pH 
of GCD2 corneal fibroblasts is higher than that of WT corneal fibro-
blasts. Accordingly, these data reveal that the increased perinuclear 
accumulation of lysosomes could not be related to lysosomal pH in 
GCD2. This interpretation is supported by a study that bafilomycin 
A1 treatments (as an elevator of lysosomal pH) did not alter lysosome 
positioning in GCD2 HO corneal fibroblasts (Data S5). Additionally, 
F I G U R E  6   Level and activation of TFEB were reduced in GCD2 corneal fibroblasts. A, Western blot analysis of TFEB protein levels in 
WT and GCD2 HO in the total cell lysate, cytosolic and nuclear fractions. β-Actin as loading controls of the total protein, 14-3-3 proteins as 
loading controls of the cytosolic protein, and histone H3 as loading controls of the nucleus protein were detected. WT, WT cell lysate; HO, 
HO cell lysate. B, Quantification of relative band intensities of TFEB in (A) (n = 3). Quantification of TFEB band intensities was normalized 
for β-actin, 14-3-3 and histone H3 bands, respectively. WT, WT cell lysate; HO, HO cell lysate. (C,D) Western blotting analysis of co-
immunoprecipitated TFEB with 14-3-3 proteins. The extracts of the total protein were co-immunoprecipitated with anti-TFEB and anti-14-
3-3 protein antibodies, respectively. The immunoprecipitates were analysed by Western blotting with antibodies against 14-3-3 proteins (C) 
and TFEB (D). IP, immunoprecipitation. WB, Western blots. WT, WT cell lysate; HO, HO cell lysate. E, Quantification of band intensities of 
14-3-3 proteins. Quantification of band intensities was normalized to TFEB (n = 3). WT, WT cell lysate; HO, HO cell lysate. F, Graph showing 
the quantification of TFEB (D) (n = 3). Quantification of band intensities was normalized to 14-3-3 protein. WT, WT cell lysate; HO, HO 
cell lysate. G, Immunofluorescence confocal microscopy of the subcellular distribution of TFEB in WT and HO corneal fibroblasts. Corneal 
fibroblasts were fixed, permeabilized with cold methanol and stained with antibodies against TFEB. Bars, 20 µm. IP, immunoprecipitation. H, 
Immunofluorescence confocal microscopy showed the nuclear distribution of TFEB in WT and HO corneal fibroblasts. I, Quantification of 
the relative dot number in the nucleus of WT and HO corneal fibroblasts. At least 20 corneal fibroblasts were analysed for each group. Data 
are representative of three independent experiments. Values are expressed as the mean ± SD. Differences between values were analysed 
by Student's t test. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001. NS, not significant
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the exact mechanisms for the perinuclear area of the lysosomes in 
GCD2 corneal fibroblasts require further investigation.
We here showed a reduced level of the ATPase E subunit in 
GCD2 corneal fibroblasts. Although the exact mechanisms of how 
the V-ATPase E subunit was reduced, and whether the reduction of 
this E subunit can elevate lysosomal pH remain to be elucidated, the 
reduced V-ATPase E subunit may reveal evidence of an elevated pH 
in GCD2 corneal fibroblasts. This finding might be supported by a 
previous study demonstrating that the mutations of the V-ATPase E 
subunit disrupt the disassembly of the V-ATPase and affect catalytic 
activity.42 Collectively, these data indicate that elevated lysosomal 
pH contributes to the failure of pathogenic mutant-TGFBIp degra-
dation and CTS maturation and can render GCD2 corneal fibroblasts 
more vulnerable to toxic stimuli that cause further dysfunction.
The quantitative relations between protein and RNA are fun-
damental questions in molecular biology that are still not fully un-
derstood. In this study, the levels of LAMP2 showed significant 
changes at the protein level in GCD2 cells, but not at the mRNA 
level. We speculate that this difference may result from reduced 
protein turnover rather than from an increased rate of synthesis. 
Because it is possible that LAMP2 could be degraded by cathepsin L, 
LAMP2 levels may increase as a result of a reduction in cathepsin L 
in GCD2 cells. This conjecture is supported by a study that shows a 
reduction in LAMP2 levels in conjunction with an overexpression of 
cathepsin L, and an increase in LAMP2 levels in the presence of cys-
teine cathepsin inhibitor.3 In addition, we cannot rule out the pos-
sibility that increased lysosomal pH and reduced lysosomal activity 
affect the turnover of LAMP2.
In this study, exogenous CTSL expression reduced pathogenic 
mutant-TGFBIp levels in GCD2 corneal fibroblasts but not in WT 
corneal fibroblasts. In contrast, CTSL expression elevated the level 
of LC3-II in WT corneal fibroblasts but decreased the level in GCD2 
corneal fibroblasts. Further, treatment with bafilomycin A1 and CTSL 
inhibitors suggested that CTSL level is associated with autophagic 
fluxes. Moreover, the levels of CTSL affected only corneal fibro-
blasts characterized by defective autophagy or reduced CTSL. These 
data indicate that CTSL can clear mutant-TGFBIp by activating au-
tophagy in GCD2 corneal fibroblasts. Accordingly, we here suggest 
that enhancing CTSL activity is a promising strategy for preventing 
and treating GCD2.
It is also possible that elevated LC3-II levels in GCD2 corneal fi-
broblasts can be caused by reduced CTSL levels. This interpretation 
is supported by the finding that inhibition of CTSB or CTSL led to 
intracellular LC3-II accumulation. Further, another study of LC3-II 
accumulation in autophagosomes or lysosomes in the presence of 
CTSL inhibitor43,44 supports this idea. Accordingly, reduced CTSL 
delays the degradation of mutant-TGFBIp and LC3-II and subse-
quently leads to the accumulation of LC3-II and mutant-TGFBIp in 
F I G U R E  7   Effects of TFEB expression on mutant-TGFBIp levels and lysosomal dysfunctions in GCD2 corneal fibroblasts. A, Western 
blot analysis of TFEB, TGFBIp, LC3, LAMP2, CTSB, CTSD, CTSK, CTSL and V-ATPase E in HO and HO-Lenti-TFEB corneal fibroblasts. B, 
Quantification of relative band intensities of Western blot results in (A). Quantification of band intensities was normalized to β-actin band 
(n = 3). C, Immunofluorescence staining for TFEB in HO and HO-Lenti-TFEB corneal fibroblasts. D, Western blots of PARP1, Cl-PARP1, 
Casp-3, Cl-Casp-3 and β-actin in HO and HO-Lenti-TFEB corneal fibroblasts. E, Quantification of relative band intensities of Cl-PARP1 in 
(D) (n = 3). Data are representative of three independent experiments. Values are expressed as the mean ± SD. Differences between values 
were analysed by Student's t test. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001. NS, not significant
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lysosomes and autophagolysosomes, which are the pathological 
features of GCD2 corneal fibroblasts. These findings support the 
hypothesis that the accumulation of pathogenic mutant-TGFBIp in 
GCD2 corneal fibroblasts (Data S1 and another study13) is caused by 
lysosomal abnormalities and consequently could contribute to the 
development of cytotoxicity.
The accumulation of mutant-TGFBIp in autophagolysosome 
and lysosomes was sufficient to induce toxicity in corneal fibro-
blasts.13,45 Accordingly, strategies for reducing pathogenic mu-
tant-TGFBIp could provide therapeutic effects. This has been 
evaluated in a study in which TGFBI expression was repressed by 
a TGF-β signalling inhibitor18 and clearance of mutant-TGFBIp by 
autophagy induction in GCD2 corneal fibroblasts.13,16,19 Another 
study showed that lysosomes receive mutant-TGFBIp via the endo-
cytic pathway in corneal fibroblasts and corneal epithelial cells.14 
However, additional studies are needed to develop this treatment 
strategy. Recent studies suggest a potential role for TFEB as a new 
therapeutic target for diverse diseases that are linked to impaired 
autophagy and lysosomal function. Therefore, we hypothesized 
that TFEB activity is involved in lysosomal abnormalities, and en-
hancement of TFEB can rescue the impaired autophagy-lysosome 
pathway of GCD2 corneal fibroblasts. In support of this hypothe-
sis, we found that TFEB activation and expression were reduced in 
GCD2 corneal fibroblasts. Furthermore, most importantly, exoge-
nous TFEB expression not only promoted autophagosome forma-
tion (as shown by elevated LC3-II levels) but also restored lysosomal 
function (as shown by up-regulated CTSK and CTSL expression), 
which ultimately restored the disrupted lysosomal dysfunction.
Besides autophagy-lysosomal systems regulation, TFEB par-
ticipates in various biological functions.46 The present study also 
showed the protective effects of TFEB (such as the reduced cleav-
age of PARP1) against the apoptosis of GCD2 corneal fibroblasts 
induced by CTSL inhibitor. These findings suggest that the activa-
tion of TFEB could protect the degeneration of corneal fibroblasts 
of GCD2 patients. However, it is currently unknown how TGFBI 
mutation influences the level of TFEB. There is increasing evi-
dence to support that expression of peroxisome proliferator-ac-
tivated receptor-gamma coactivator-1alpha (PGC-1α) co-activates 
the expression of TFEB.47 Recently, it was reported that PGC-1α 
can robustly induce the expression of TFEB and rescue proteotox-
icity in a mouse model of Huntington's disease.48,49 These studies 
showed that PGC-1α can rescue the impaired TFEB induction and 
significantly reduce TFEB expression by PGC-1α reduction. Another 
study showed that PGC-1α expression directly parallels the level 
of TFEB.50,51 In addition, TFEB translocation from the cytosol to 
the nucleus was impaired in the absence of PGC-1α.52 Although it 
remains unclear whether the pathogenic mutation causes a loss-
of-function or gain-of-function of TGFBIp, Maeng et al showed 
that TGFBIp activates focal adhesion kinase (FAK) signalling.53 
Furthermore, a recent study showed that phosphorylation of FAK 
was enhanced by TGFBIp and was suppressed significantly by 
an integrin α5β1 inhibitor.54 Considering that TGFBIp interacts 
with several integrins55 including α5β1,56 these data indicate that 
TGFBIp is an upstream regulator of the integrin/FAK/PGC-1α sig-
nalling pathway. Accordingly, TFEB in GCD2 corneal fibroblasts can 
be reduced by reduced integrin/FAK/PGC-1α signalling. Therefore, 
we here predict that PGC-1α is reduced in GCD2 corneal fibro-
blasts and thereby reduces the level of TFEB. Collectively, TFEB 
is a potential therapeutic target for maintaining the physiological 
function of corneal fibroblasts from the dysfunction of autophagy 
and lysosomes. Preclinical studies are also needed to evaluate the 
consequence of TFEB overexpression or activation as a candidate 
therapeutic target for treating GCD2.
ACKNOWLEDG EMENTS
This study was supported by the Basic Science Research Program 
through the National Research Foundation of Korea (NRF), funded 
by the Ministry of Education (NRF-2016R1D1A1B03934794) and 
by the Korea Health Technology R & D Project, through the Korea 
Health Industry Development Institute (KHIDI), funded by the 
Ministry of Health & Welfare, Republic of Korea (No. HI16C1009).
CONFLIC T OF INTERE S T
Dr EK Kim is a member of the medical advisory board of the Avellino 
LAB in the USA. The remaining authors have no financial or propri-
etary interest in the materials presented herein.
AUTHOR CONTRIBUTION
Seung-il Choi: Conceptualization (equal); Data curation (equal); 
Formal analysis (equal); Funding acquisition (equal); Investigation 
(equal); Methodology (equal); Project administration (equal); 
Resources (equal); Software (equal); Supervision (equal); Validation 
(equal); Visualization (equal); Writing-original draft (equal); Writing-
review & editing (equal). Jong Hwan Woo: Data curation (equal); 
Investigation (equal); Methodology (equal); Project administra-
tion (equal); Software (equal); Visualization (equal). Eung Kweon 
Kim: Conceptualization (equal); Data curation (equal); Formal 
analysis (equal); Funding acquisition (equal); Investigation (equal); 
Methodology (equal); Project administration (equal); Resources 
(equal); Software (equal); Supervision (equal); Validation (equal); 
Visualization (equal); Writing-original draft (equal); Writing-review & 
editing (equal).
DATA AVAIL ABILIT Y S TATEMENT
I confirm that I have included a citation for available data in my refer-
ences section, unless my article type is exempt.
ORCID
Seung-il Choi  https://orcid.org/0000-0001-7168-8795 
R E FE R E N C E S
 1. Klintworth GK. Advances in the molecular genetics of corneal dys-
trophies. Am J Ophthalmol. 1999;128:747–754.
 2. Lee JH, Cristol SM, Kim WC, et al. Prevalence of granular corneal 
dystrophy type 2 (Avellino corneal dystrophy) in the Korean popu-
lation. Ophthalmic Epidemiol. 2010;17:160–165.
10354  |     CHOI et al.
 3. West-Mays JA, Dwivedi DJ. The keratocyte: corneal stromal 
cell with variable repair phenotypes. Int J Biochem Cell Biol. 
2006;38:1625–1631.
 4. Fini ME. Keratocyte and fibroblast phenotypes in the repairing cor-
nea. Prog Retin Eye Res. 1999;18:529–551.
 5. Mehrpour M, Esclatine A, Beau I, et al. Autophagy in health and 
disease. 1. Regulation and significance of autophagy: an overview. 
Am J Physiol Cell Physiol. 2010;298:C776–C785.
 6. Mizushima N, Komatsu M. Autophagy: renovation of cells and tis-
sues. Cell. 2011;147:728–741.
 7. Turk V, Stoka V, Vasiljeva O, et al. Cysteine cathepsins: from struc-
ture, function and regulation to new frontiers. Biochim Biophys Acta. 
2012;1824:68–88.
 8. Kaminskyy V, Zhivotovsky B. Proteases in autophagy. Biochim 
Biophys Acta Proteins Proteomics. 2012;1824(1):44–50.
 9. Punnonen EL, Autio S, Marjomäki VS, et al. Autophagy, cathepsin L 
transport, and acidification in cultured rat fibroblasts. J Histochem 
Cytochem. 1992;40:1579–1587.
 10. Uchiyama Y. Autophagic cell death and its execution by lysosomal 
cathepsins. Arch Histol Cytol. 2001;64:233–246.
 11. Erickson AH. Biosynthesis of lysosomal endopeptidases. J Cell 
Biochem. 1989;40:31–41.
 12. Ishidoh K, Kominami E. Processing and activation of lysosomal pro-
teinases. Biol Chem. 2002;383:1827–1831.
 13. El Kochairi I, Letovanec I, Uffer S, et al. Systemic investigation of 
keratoepithelin deposits in TGFBI/BIGH3-related corneal dystro-
phy. Mol Vis. 2006;12:461–466.
 14. Choi SI, Kim BY, Dadakhujaev S, et al. Impaired autophagy and 
delayed autophagic clearance of transforming growth factor be-
ta-induced protein (TGFBI) in granular corneal dystrophy type 2. 
Autophagy. 2012;8:1782–1797.
 15. Choi S-I, Maeng Y-S, Kim T-I, et al. Lysosomal trafficking 
of TGFBIp via caveolae-mediated endocytosis. PLoS One. 
2015;10:e0119561.
 16. Choi SI, Kim EK. Autophagy in granular corneal dystrophy type 2. 
Exp Eye Res. 2016;144:14–21.
 17. Choi S-I, Kim KS, Oh J-Y, et al. Melatonin induces autophagy via an 
mTOR-dependent pathway and enhances clearance of mutant-TG-
FBIp. J Pineal Res. 2013;54:361–372.
 18. Choi S-I, Lee E, Jeong JB, et al. 4-Phenylbutyric acid reduces mu-
tant-TGFBIp levels and ER stress through activation of ERAD path-
way in corneal fibroblasts of granular corneal dystrophy type 2. 
Biochem Biophys Res Commun. 2016;477:841–846.
 19. Choi SI, Kim BY, Dadakhujaev S, et al. Inhibition of TGFBIp expres-
sion by lithium: implications for TGFBI-linked corneal dystrophy 
therapy. Invest Ophthalmol Vis Sci. 2011;52:3293–3300.
 20. Nie D, Peng Y, Li M, et al. Lithium chloride (LiCl) induced autophagy 
and downregulated expression of transforming growth factor be-
ta-induced protein (TGFBI) in granular corneal dystrophy. Exp Eye 
Res. 2018;173:44–50.
 21. Traganos F, Darzynkiewicz Z. Lysosomal proton pump activity: su-
pravital cell staining with acridine orange differentiates leukocyte 
subpopulations. Methods Cell Biol. 1994;41:185–194.
 22. Kågedal K, Zhao M, Svensson I, et al. Sphingosine-induced 
apoptosis is dependent on lysosomal proteases. Biochem J. 
2001;359:335–343.
 23. Porter K, Nallathambi J, Lin Y, et al. Lysosomal basification and de-
creased autophagic flux in oxidatively stressed trabecular mesh-
work cells Implications for glaucoma pathogenesis. Autophagy. 
2013;9:581–594.
 24. Shi BO, Huang Q-Q, Birkett R, et al. SNAPIN is critical for lysosomal 
acidification and autophagosome maturation in macrophages. 
Autophagy. 2017;13:285–301.
 25. Boya P, Kroemer G. Lysosomal membrane permeabilization in cell 
death. Oncogene. 2008;27:6434–6451.
 26. Kirkegaard T, Roth AG, Petersen NHT, et al. Hsp70 stabilizes lyso-
somes and reverts Niemann-Pick disease-associated lysosomal pa-
thology. Nature. 2010;463:549–553.
 27. Sardiello M, Palmieri M, di Ronza A, et al. A gene network regulating 
lysosomal biogenesis and function. Science. 2009;325:473–477.
 28. Palmieri M, Impey S, Kang H, et al. Characterization of the CLEAR 
network reveals an integrated control of cellular clearance path-
ways. Hum Mol Genet. 2011;20:3852–3866.
 29. Heuser J. Changes in lysosome shape and distribution correlated 
with changes in cytoplasmic pH. J Cell Biol. 1989;108:855–864.
 30. Pu J, Guardia CM, Keren-Kaplan T, et al. Mechanisms and functions 
of lysosome positioning. J Cell Sci. 2016;129:4329–4339.
 31. Settembre C, Di Malta C, Polito VA, et al. TFEB links autophagy to 
lysosomal biogenesis. Science. 2011;332:1429–1433.
 32. Settembre C, Fraldi A, Jahreiss L, et al. A block of autophagy in lyso-
somal storage disorders. Hum Mol Genet. 2008;17:119–129.
 33. Vergarajauregui S, Connelly PS, Daniels MP, et al. Autophagic 
dysfunction in mucolipidosis type IV patients. Hum Mol Genet. 
2008;17:2723–2737.
 34. Richo GR, Conner GE. Structural requirements of procathepsin D 
activation and maturation. J Biol Chem. 1994;269:14806–14812.
 35. Kokkonen N, Rivinoja A, Kauppila A, et al. Defective acidification of 
intracellular organelles results in aberrant secretion of cathepsin D 
in cancer cells. J Biol Chem. 2004;279:39982–39988.
 36. Barrett AJ, Cathepsin D. Purification of isoenzymes from human 
and chicken liver. Biochem J. 1970;117:601–607.
 37. Gukovsky I, Pandol SJ, Gukovskaya AS. Organellar dysfunc-
tion in the pathogenesis of pancreatitis. Antioxid Redox Signal. 
2011;15:2699–2710.
 38. Katunuma N. Posttranslational processing and modification of 
cathepsins and cystatins. J Signal Transduct. 2010;2010:375345.
 39. Jongsma M, Berlin I, Wijdeven R, et al. An ER-associated pathway 
defines endosomal architecture for controlled cargo transport. Cell. 
2016;166:152–166.
 40. Korolchuk VI, Rubinsztein DC. Regulation of autophagy by lyso-
somal positioning. Autophagy. 2011;7:927–928.
 41. Johnson DE, Ostrowski P, Jaumouille V, et al. The position of ly-
sosomes within the cell determines their luminal pH. J. Cell Biol. 
2016;212:677–692.
 42. Okamoto-Terry H, Umeki K, Nakanishi-Matsui M, et al. Glu-
44 in the amino-terminal alpha-helix of yeast vacuolar ATPase 
E subunit (Vma4p) has a role for VoV1 assembly. J Biol Chem. 
2013;288:36236–36243.
 43. Ueno T, Takahashi K. A cathepsin L-specific inhibitor preferentially 
inhibits degradation of autophagosomal LC3 and GABARAP in 
HeLa and Huh-7 cells. Autophagy. 2009;5:878–879.
 44. Takahashi K, Ueno T, Tanida I, et al. Characterization of CAA0225, 
a novel inhibitor specific for cathepsin L, as a probe for autophagic 
proteolysis. Biol Pharm Bull. 2009;32:475–479.
 45. Choi S-I, Maeng Y-S, Kim KS, et al. Autophagy is induced by rap-
tor degradation via the ubiquitin/proteasome system in gran-
ular corneal dystrophy type 2. Biochem Biophys Res Commun. 
2014;450:1505–1511.
 46. Raben N, Puertollano R. TFEB and TFE3: linking lysosomes to cellu-
lar adaptation to stress. Annu Rev Cell Dev Biol. 2016;32:255–278.
 47. La Spada AR. PPARGC1A/PGC-1 alpha, TFEB and enhanced pro-
teostasis in Huntington disease defining regulatory linkages be-
tween energy production and protein-organelle quality control. 
Autophagy. 2012;8:1845–1847.
 48. Tsunemi T, Ashe TD, Morrison BE, et al. PGC-1alpha rescues 
Huntington's disease proteotoxicity by preventing oxidative stress 
and promoting TFEB function. Sci Transl Med. 2012;4:142ra97.
 49. Tsunemi T, Ashe TD, Morrison BE, et al. PGC-1 alpha rescues 
Huntington's disease proteotoxicity by preventing oxidative stress 
and promoting TFEB function. Sci Transl Med. 2012;4:142ra97.
     |  10355CHOI et al.
 50. Vainshtein A, Desjardins EM, Armani A, et al. PGC-1alpha modu-
lates denervation-induced mitophagy in skeletal muscle. Skelet 
Muscle. 2015;5:9.
 51. Vainshtein A, Tryon LD, Pauly M, et al. Role of PGC-1alpha during 
acute exercise-induced autophagy and mitophagy in skeletal mus-
cle. Am J Physiol Cell Physiol. 2015;308:C710–C719.
 52. Erlich AT, Brownlee DM, Beyfuss K, et al. Exercise induces TFEB ex-
pression and activity in skeletal muscle in a PGC-1alpha-dependent 
manner. Am J Physiol Cell Physiol. 2018;314:C62–C72.
 53. Maeng Y-S, Aguilar B, Choi S-I, et al. Inhibition of TGFBIp expres-
sion reduces lymphangiogenesis and tumor metastasis. Oncogene. 
2016;35:196–205.
 54. Lin T, Zhang X, Lu Y, et al. TGFBIp mediates lymphatic sprouting in 
corneal lymphangiogenesis. J Cell Mol Med. 2019;23(11):7602–7616.
 55. Son HN, Nam JO, Kim S, et al. Multiple FAS1 domains and the RGD 
motif of TGFBI act cooperatively to bind alphavbeta3 integrin, lead-
ing to anti-angiogenic and anti-tumor effects. Biochim Biophys Acta. 
2013;1833:2378–2388.
 56. Ma J, Cui W, He SM, et al. Human U87 astrocytoma cell invasion 
induced by interaction of betaig-h3 with integrin alpha5beta1 in-
volves calpain-2. PLoS One. 2012;7:e37297.
SUPPORTING INFORMATION
Additional supporting information may be found online in the 
Supporting Information section.
How to cite this article: Choi S-I, Hwan Woo J, Kweon Kim E. 
Lysosomal dysfunction of corneal fibroblasts underlies the 
pathogenesis of Granular Corneal Dystrophy Type 2 and can 
be rescued by TFEB. J Cell Mol Med. 2020;24:10343–10355.  
https://doi.org/10.1111/jcmm.15646
